6505--Notice of Intent to Sole Source F-18 Piflufolastat (Pylarify for the George E. Wahlen VA Medical Center in Salt Lake City, Utah.
Closed Special Notice Posted
- Solicitation number
- 36C25926Q0213
- Agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Integrated Service Network 19 (NCO 19) issued a Notice of Intent to Sole Source on January 27, 2026, for the procurement of Pylarify (piflufolastat F-18) radiopharmaceutical injections for the George E. Wahlen VA Medical Center in Salt Lake City, Utah. The VA intends to award a task order on a sole source basis to Progenics Pharmaceuticals, Inc., under FAR Part 8 authority. This procurement is classified under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals), with an estimated value of $34 million. The notice allows interested parties to demonstrate alternative capabilities before the Government makes its final award determination. The Contracting Officer for this opportunity is Heather Chase at heather.chase2@va.gov.
The procurement objective is to continue providing unit dose syringes of F-18 Piflufolastat for positron emission tomography (PET) imaging as ordered by the Nuclear Medicine Department, with the radiopharmaceutical used diagnostically to detect pathologies including cancer, osteomyelitis, cardiac ischemia, and infection. Interested parties must submit responses demonstrating their capability to meet the requirement by 3:00 PM Mountain Standard Time on Wednesday, February 4, 2026, including relevant specifications, cut sheets, brochures, and capability statements. To be eligible, contractors must be local to the facility (within 60 minutes), possess a cyclotron within two hours, hold current and unrevoked licenses from the State of Utah, NRC, and/or FDA, and have personnel who are licensed nuclear pharmacists or technologists supervised by nuclear pharmacists. The Statement of Work requires daily deliveries Monday through Friday by 8:00 AM MST, emergency delivery capability within two hours during normal working hours, compliance with USP 797 and 825 guidelines, and acceptance of returns for credit under specified conditions. All radiopharmaceuticals must maintain a two-hour expiration time and be prepared by certified nuclear medicine pharmacists according to manufacturer specifications.
Notice text
INTENT TO SOLE SOURCE
THIS IS NOT A SOLICITATION OR REQUEST FOR OFFERS. NO SOLICITATION PACKAGE IS AVAILABLE NOR WILL TELEPHONE REQUESTS BE HONORED. NO SOLICITATION WILL BE POSTED TO CONTRACT OPPORTUNITIES.
PROCUREMENT TITLE: Pylarify Radiopharmaceuticals
INTENT TO AWARD: The Department of Veterans Affairs (NCO 19), 6162 S. Willow Drive, Greenwood Village, CO 80111, intends to award one (1) task order on a sole source basis, to Progenics Pharmaceuticals, Inc., for PYLARIFY® (piflufolastat F 18) Injections.
BACKGROUND AND DESCRIPTION: This procurement is for the continued providing of unit dose syringes of F-18 Piflufolastat (Pylarify) for positron emitting tomography (PET) imaging as ordered by the Nuclear Medicine Department.
Pylarify is a radiopharmaceutical, or medicinal radio-compound, and contains radioactive isotopes. Radiopharmaceuticals can be used as diagnostic and therapeutic agents to diagnose specific pathologies, such as cancer, osteomyelitis, cardiac ischemia, and infection.
NAICS: 325412 Pharmaceutical Preparation Manufacturing, $34 Million
PSC: 6505 Drugs and Biologicals
AUTHORITY: This procurement will be issued under the authority of FAR Part 8 Required Sources of Supplies and Services. A determination by the Government not to compete this proposed award upon response to this notice is solely within the discretion of the Contracting Officer.
INTERESTED PARTIES: THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTES. Interested parties may identify their interest and capability to respond to this requirement as described in the attached Statement of Work no later than 3:00 PM Mountain Standard Time, Wednesday, February 4th, 2026. Information received in response to this notice must clearly demonstrate the capability of meeting the Government s need as stated above. Include any relevant information (specifications, cut sheets, brochures, capability statement, etc.) confirming the ability to supply the products and/or any services outlined in this notice. Responses to this notice are to be sent to heather.chase2@va.gov.
A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. The Government is not responsible for any potential costs incurred from interested parties desiring to respond to this notice.
ATTACHED: Statement of Work
Files
| File | Type | Posted |
|---|---|---|
| 36C25926Q0213.docx | DOCX document | |
| Statement of Work.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--General Radioisotopes (Diagnostic & Therapeutic) | Veterans Integrated Service Network 19 | No set-aside | |
| 6505--Sources Sought VISN2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS | Veterans Integrated Service Network 2 | No set-aside | |
| 6515--pyxis IV prep | Veterans Integrated Service Network 22 | No set-aside | |
| J065--Fort Harrison GE Precision Radiology Preventive Maintenance | Veterans Integrated Service Network 19 | No set-aside | |
| Bayesian Dosing Software | Veterans Integrated Service Network 19 | Total Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity